ABSTRACT The kinetics of both erythroid burst-forming and colony-forming units (BFU-E, CFU-E) and myelomonocytic precursors [myelomacrophage colony-forming unit (CFU-C)J have been evaluated in tibial marrow, peripheral blood, and spleen of DBA/2 mice at time intervals after inoculation of either the anemic (FLy-A) or the polycythemic (FLV-P) strain of Friend leukemia virus. Either one of the viruses induced, at 7-10 days after infection, a massive increase in the number of BFU-Es in peripheral blood, in parallel with their depletion in tibial marrow and increase in spleen. A comparable increase in the blood BFU-E number was observed in splenectomized FLV-infected mice. These results indicate a marrow-spleen migration of BFU-Es. In spleen, the increase of the BFU-E number was associated with an increase in the CFU-E pool. In tibial marrow, a sequence of expansion/depletion waves occurred reciprocally at the level of BFU-E and CFU-E. The cycling of BFLT-E ([3Hthymidine in vitro suicide index) in marrow, blood, and spleen was enhanced, whereas that of CFU-E and CFU-C showed little or no modification. These kinetic data suggest that the main target cell of FLV may be the BFU-E or a closely related element. In plates without added erythropoietin (but containing it in fetal calf serum), expression of CFU-E from FLV-P-treated animals was maximal; that of CFU-E from FLV-A-injected mice was either virtually absent or only slight in marrow or spleen, respectively. BFU-E growth always was fully dependent upon erythropoietin addition. Control studies in FLV-infected resistant mice and in susceptible mice given diluted or heat-inactivated virus provide convincing evidence that the phenomena described are induced by FLV.
Several in vivo aspects of Friend leukemia virus (FLV)-induced leukemia are still open to debate. At least two strains of FLV are known. The prototype virus, the anemic strain (FLV-A), induces an erythroleukemia associated with anemia, as did the original isolate (1, 2) . A second strain, the polycythemic strain (FLV-P), subsequently described by Mirand (3) , causes an erythroleukemia associated with polycythemia. FLV-P contains at least two viruses, the spleen focus-forming virus, which is defective and forms spleen foci within 9 days of inoculation (4) , and a "helper" lymphatic leukemia virus (5) , which induces leukemia after a long incubation period (for review, see ref. 6 ). It has been postulated that the early erythroleukemia induced by FLV-P is caused by the spleen focus-forming component (6) , although the leukemia is indistinguishable from that induced by FLV-A, which does not have any detectable spleen focus-forming activity.
Although an erythroid precursor has been implicated as the FLV target cell in vivo (7) , this has not been demonstrated so far by clonal assays. In addition, the kinetic mechanisms underlying FLV-induced erythroleukemia have not been fully investigated. The availability of adequate clonal assays of erythroid precursors (8, 9) makes such studies feasible. These techniques have allowed identification of at least two erythroid precursors in normal murine marrow and spleen, termed, respectively, "erythroid burst-forming unit" (BFU-E) and "colony-forming unit" (CFU-E). It is generally accepted that the BFU-E, strictly related to the pluripotent stem cell compartment [spleen colony-forming unit (CFU-S)], feeds the CFU-E pool, which finally differentiates to the erythroblastic stage. Hara and Ogawa (10) have also identified BFU-Es circulating in the peripheral blood; in stress erythropoiesis, migration of these elements from marrow to spleen via blood has been reported (11) .
An expansion of CFU-E pool size in marrow and spleen of DBA/2 mice given FLV-P has been observed (12) . The present studies focused on the kinetics (pool size and proliferative rate) of BFU-E, CFU-E, and myelomacrophage colony-forming units (CFU-C) in marrow, spleen, and peripheral blood of highly susceptible DBA/2 mice and of resistant BALB/c and C57BL/6 mice inoculated with either one of the N-tropic FLV strains.
MATERIALS AND METHODS Viruses. N-tropic, cell-free homogenates of FLV-A and FLV-P were prepared as described (1) and passaged in our laboratory. Virus stock titers were: FLV-P, 10-48 LD5o/0.2 ml; FLV-A, 10-32 LD5o/0.2 ml. Both strains were devoid of lactic dehydrogenase virus.
Mice. DBA/2 mice of both sexes, [7] [8] [9] [10] [11] [12] weeks old (from CNEN-Casaccia, and Charles River Italia, Calco, Italy), and BALB/c or C57BL/6 female mice of comparable age (Charles River Italia) were housed 10 per cage and fed with laboratory pellets and tap water ad libitum. The animals received FLV-P or FLV-A intraperitoneally (0.2 or 0.3 ml per mouse, respectively).
Number and In Vitro Killing Index of BFU-E, CFU-E, and CFU-C. The numbers of BFU-E, CFU-E, and CFU-C in tibial marrow, spleen, or peripheral blood were evaluated at time intervals after FLV infection. In some studies, mice were subjected to splenectomy or sham-operation under light ether anesthesia 6 hr prior to virus infection. All experimental points, except those after splenectomy, were repeated at least three times. Each group consisted of at least three mice. Two plates per group were always used. The assays of BFU-E, CFU-E, and CFU-C were performed by means of methylcellulose cultures, according to a slight modification (13) of a previously reported method (9) . Peripheral blood BFU-Es were analyzed as described (10 ternational units) or lung-conditioned medium (0.1 ml). Preliminary experiments indicated that these amounts induced maximal growth of BFU-E, CFU-E, and CFU-C colonies under the various conditions evaluated here. Human urinary erythropoietin was purified as described (13) . The lung-conditioned medium was prepared as before (13) .
The killing index of BFU-E, CFU-E, and CFU-C was evaluated according to a slight modification (14) of the in vitro [3H]thymidine method (9) . Control studies (9, 14) (13) .
RESULTS

Clonal Analysis of Erythroid Precursors in Marrow,
Spleen, and Peripheral Blood. Infection with either FLV-P or FLV-A induced a dramatic increase in the BFU-E number in peripheral blood, which was characterized by an initial increase (days 5-10) and a subsequent plateau (FLV-A) or a further increase (FLV-P) (days 10-20) (Fig. 1 ). The increase caused by FLV-P was larger than that with FLV-A (470-fold and 75-fold, respectively, over control values). These findings suggest that a massive migration of erythroid precursors occurs. Therefore, the sizes of the splenic and marrow BFU-E pools were measured to determine whether the flow of this migration was from marrow to spleen. The increase in the number of BFU-E in the blood on days [5] [6] [7] [8] [9] [10] paralleled an increase in the spleen and showed an inverse relationship with the BFU-E pool in marrow (Figs. 2 and 3). The postulate of marrow-to-spleen BFU-E migration is further strengthened by results of experiments in splenectomized mice. In spleen-ablated DBA/2 mice infected with FLV-P or FLV-A-on day 0, there was a striking increase in the BFU-E number in blood (FLV-P, 861/ml; FLV-A, 672) on day 12 compared with that in noninfected animals (sham-operated, 9; splenectomized, 42). This increase was slightly larger than in the infected, sham-operated controls (FLV-P, 713; FLV-A, 599).
The number of BFU-Es in the blood continued to increase on days 10-20 after FLV-P infection and paralleled the levels of BFU-E in the spleen in spite of BFU-E/CFU-E differentiation ( Figs. 1 and 3B ). On the other hand, in FLV-A-infected mice, the plateau phase of BFU-E in the blood on days [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] was associated with a decrease in the number of BFU-E in the spleen, apparently due to differentiation of BFU-E to CFU-E (Figs. 1 and 2B). In this respect, it is noteworthy that the amplification of the splenic CFU-E pool was larger in FLV-A-than in FLV-P-infected mice (Figs. 2B and 3B).
In regard to marrow kinetics, the size of both the BFU-E and the CFU-E pool showed an oscillatory pattern after FLV Fig. 2 except that the mice received FLV-P and only a single experiment was performed on day 7. infection ( Fig. 2A ). An early increase in the BFU-E number on days 1 and 2.5 was followed by a progressive decrease with a nadir on day 10, a second wave of amplification on day 15 , and a final decrease on day 20. The kinetic pattern of CFU-E was the reverse of that of BFU-E, with peak values on days 10 and 20. It is of interest that the kinetics of the CFU-C pool in both marrow and spleen were similar to the kinetics observed for the BFU-E compartment, although the early amplification at the level of the tibial BFU-E pool was not observed for the CFU-C population ( Fig. 2 A and B) .
After infection with FLV-P, the BFU-E pool in tibia showed a less-well-defined pattern than after FLV-A (Fig. 3A) . However, the size of the CFU-E pool was characterized by a sequence of depletion/amplification waves which resemble those observed after FLV-A infection ( Figs. 2A and 3A) . The kinetics of the CFU-C pool apparently resemble those of the BFU-E population ( Fig. 3 A and B) .
Cycling of Hemopoietic Precursors in Marrow, Spleen, and Peripheral Blood. The number of BFU-E in DNA synthesis in marrow, blood, and spleen, as evaluated on the basis of the percentage in vitro killing by [3H]thymidine, was markedly enhanced after FLV-A or FLV-P infection ( Table  1) . The results of two representative experiments at 10 and 15 days after infection are shown in Table 1 . These results confirm that the killing index for these precursors in peripheral blood is virtually null (15) . In contrast, the number of CFU-E and CFU-C in DNA synthesis was only slightly modified or not modified at all by infection with either strain of FLV. Furthermore, the cycling activity of CFU-E appeared to be similar when these precursors were plated in cultures with and without added erythropoietin (except that tibial CFU-E from day 15 FLV-A-infected mice required erythropoietin addition for significant in vitro growth).
Growth of Erythroid Colonies Without Addition of
Erythropoietin. In all studies, the growth of BFU-E was totally dependent upon addition of erythropoietin (Figs. 1-3) . In contrast, the growth of CFU-E colonies from FLV-P-infected mice was independent of the addition of erythropoietin starting from days 5-7 after virus inoculation (Fig. 3 A and B) . On the other hand, the splenic CFU-E pool from FLV-A-infected mice was only to a minor extent independent of the addition of erythropoietin-i.e., the ratio between Ep+ and Ep-colonies was always >3:1-whereas tibial CFU-E were totally erythropoietin dependent (Fig. 2 A and B) .
Control Studies. The temporal correlation observed between virus infection and fluctuations of BFU-E, CFU-E, and CFU-C pool sizes was further investigated to verify the existence of a cause/effect relationship. The pools of spleen BFU-E and CFU-E from DBA/2 mice evaluated at days 10-20 after injection of either heat-inactivated virus (FLV-P or FLV-A held at 560C for 1 hr) or spleen homogenate from normal DBA/2 mice did not show any significant change (data not shown). In addition, the results of a dose-response experiment indicated that, on day 10 after FLV-P infection, the magnitude of BFU-E, CFU-E, and CFU-C amplification in the spleen was clearly dependent upon virus concentrations (Fig. 4) .
The specificity of the effect was demonstrated by experiments performed in mouse strains partially (BALB/c, Fv-1 b/b, Fv-2s/s) or frilly (C57BL/6, Fv-2r/r) restrictive for replication of N-tropic FLV strains. The BFU-E, CFU-E, and CFU-C pool sizes in BALB/c mice given undiluted FLV-A showed no significant modification at the tibial level (Fig. 5A ). An increase in the CFU-E number was observed in the spleen, but to a smaller extent than in DBA/2 mice (Fig. 5B) . This is in line with the fact that the Fv-l gene restricts FLV replication or transformation only quantitatively-i.e., by 2-3 orders of magnitude. In C57BL/6 mice, the increase in the splenic CFU-E number upon injection of the more potent FLV-P virus was decreased to approximately 1/25th of that in DBA/2 mice (Fig.  6 ). The small difference in CFU-E number between FLVinfected and control C57BL/6 mice is probably due to nonspecific mechanism(s) contingent upon inoculation of heterologous antigenic material such as DBA/2-derived FLV-P preparations. This is further confirmed by the observation of similarly small increases of splenic CFU-Es in C57BL/6 mice given spleen homogenates from normal DBA/2 mice (data not shown).
DISCUSSION
A comprehensive evaluation of BFU-E, CFU-E, and CFU-C kinetics in marrow, spleen, and peripheral blood of mice infected with FLV-P or FLV-A has been carried out. Both viruses induce impressive fluctuations of the pool size of these pre- cursors. The cause/effect relationship between virus infection and these kinetic phenomena was established. The effect was dependent upon virus dosage and was not observed in DBA/2 mice given heat-inactivated FLV or in genetically restricted animals treated with live, undiluted FLV preparations.
The kinetic markers of FLV-induced erythroleukemia are represented by (i) a markedly enhanced proliferative rate of BFU-E in marrow, blood, and spleen, as evaluated on the basis of their in vitro [3H]thymidine suicide index and (ii) massive migration of BFU-E from marrow to spleen via the blood. These phenomena suggest that the BFU-E may be the main target cell of FLV. These in vtvo observations are compatible with results of recent in vitro studies (16) showing growth of erythroid bursts in cultures of murine marrow cells infected with FLV-P. However, the remote possibility exists that the main FLV target cell is distal to the BFU-E: both enhanced cycling and migration of BFU-E would thereby constitute a "secondary" phenomenon. This hypothesis is unlikely in view of the marked and selective enhancement of BFU-E proliferation and the dramatic increase of their pools in blood and spleen. It must be pointed out, however, that migration of both early hemopoietic precursors and stem cells is not restricted to leukemic diseases but has also been reported in stress erythropoiesis (11) and after injection of zymosan (17) . On the other hand, in view of the fact that the BFU-E is closely related to the CFU-S (18), the possibility should be considered in future studies that the latter also represents a target cell for FLV. Finally, it is emphasized that FLV action on BFU-E may be direct or mediated via enhanced production of burst-enhancing factor(s) (18) .
On the basis of these observations, it is tempting to postulate that the basic kinetic mechanism underlying FLV-induced erythroleukemia is represented by the following sequence of events. (i) The main target cell of FLV is the BFU-E, which is induced to proliferate and migrate from marrow to spleen via peripheral blood. (ii) The affected BFU-Es give rise, in the splenic microenvironment, to an explosive expansion of the CFU-E pool, which is larger in FLV-A-than in FLV-P-infected mice; this phenomenon may be accounted for by a partial blockade of CFU-E terminal differentiation after FLV-A infection, which results in both CFU-E accumulation and profound anemia. mice, the fluctuations of BFU-E and CFU-E pool sizes are apparently interconnected in that amplification of the former population is accompanied by depletion of the latter one and vce versa. This correlation may perhaps reflect a cyclic sequence of "stop and go" kinetic events, initiated by BFU-E proliferation leading to amplification of this pool and followed by differentiation of these precursors toward the CFU-E compartment. These phenomena occur in parallel to sustained BFU-E marrow-to-spleen migration, which possibly masks a similar "stop and go" mechanism at the spleen level. The kinetics of marrow CFU-E after FLV-P infection apparently resemble those after FLV-A treatment. However, several differences have been observed in response to the virus strain used. The amplification of the marrow BFU-E pool in FLV-A-infected mice represented the earliest kinetic signal of FLV infection, whereas in FLV-P-infected mice the BFU-E pattern was less well defined. In addition, the ability of CFU-E colonies to grow in the absence of added erythropoietin also differed between mice infected with FLV-A and those given FLV-P. In the former, expression of CFU-E was virtually not independent of erythropoietin addition in tibia and only slightly independent in spleen, whereas it was always totally independent in the latter. Erythropoietin-independent CFU-Es from FLV-P-infected mice have been reported (12) . These differences suggest that this independence of CFU-E is largely mediated by the spleen focus-forming component of FLV-P. This defective virus may, therefore, simply play the role of mimicking erythropoietin. Accordingly, it may facilitate the erythroid expression of the leukemogenic transformation induced by the FLV complex. This hypothesis is supported by results obtained in studies of in vitro transformation by FLV-A (19) or FLV-P (20) . In cells infected with FLV-A only, those cultures to which erythropoietin was added developed malignantly transformed erythroid colonies. On the other hand, transformation was accomplished in cells infected with FLV-P without the addition of erythropoietin.
The erythropoietin-dependent growth of BFU-E from FLV-infected mice is in apparent contrast with results obtained with the partial or total independence of CFU-E-i.e., the progeny of BFU-E. However, this phenomenon may be explained in terms of a progression toward malignancy in the course of in vivo BFU-E-to-CFU-E maturation in FLV-infected mice. These data are compatible with the contention that BFU-E differentiation is modulated also by erythropoietin (13, 14, 21) and not only by the burst-enhancing factor(s) (22) .
Kinetics of CFU-C pool size are fairly similar to those of the BFU-E population. However, the likelihood of CFU-C as target cells of FLV is dampened by lack of enhanced cycling of these precursors after FLV infection. The above similarity, already observed after erythroid perturbations (23) , may reflect the strict interrelationship existing between these precursors. An additional explanation is that granulopoiesis and monocytopoiesis are enhanced by intense antigenic stimulation (24) , as induced here by FLV infection.
